Leaflet SORAFENIB STADA 200mg film-coated tablets

Product code:
W67036002
Quantity:
112
Indicated for:
cancer
Route of administration:
oral
Substance:
sorafenib (tyrosine kinase inhibitor)
ATC
L01EX02 — Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Precautions:

Fertility warning

Fertility warning

This medicine may affect fertility.

Cytotoxic / special handling

Cytotoxic / special handling

Handle with special care.

Contraception required

Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding

Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid grapefruit

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Hepatotoxicity

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis

Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions

Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Cardiac risk / QT prolongation / arrhythmias

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Sorafenib is an antineoplastic medication used for the treatment of certain types of cancer, such as hepatocellular carcinoma, advanced renal cancer, and differentiated thyroid cancer. It works by inhibiting multiple kinases involved in tumor growth and angiogenesis.

The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to adhere to the treatment regimen and undergo regular check-ups to monitor the response to therapy.

Patients should be aware of potential side effects, such as diarrhea, fatigue, or high blood pressure. It is important to inform the doctor of any unusual symptoms.

Common side effects include diarrhea, fatigue, high blood pressure, and skin rashes. In rare cases, severe reactions such as liver injury syndrome or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about SORAFENIB STADA 200mg

Substance:
sorafenib
Date of latest medicines list:
01-06-2026
Product code:
W67036002
Concentration:
200mg
Pharmaceutical form:
film-coated tablets
Quantity:
112
Product type:
Generic medicine
Price:
1645.97 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
REMEDICA LTD - CIPRU
Holder:
STADA M&D S.R.L. - ROMANIA
Number:
13387/2020/02
Shelf life:
2 years

Concentrations available for sorafenib

  • 200mg
  • 400mg

Compensation lists for SORAFENIB STADA 200mg STADA

NHP 3 (C2) - NHP oncology

Price
1645.97 RON
Copayment
1645.97 RON
Patient
0.00 RON